Medicine and Science from The BMJ - podcast cover

Medicine and Science from The BMJ

The BMJ brings you interviews with the people who are shaping medicine and science around the world.
Last refreshed:
Follow this podcast in the Metacast mobile app to refresh it and see new episodes.
Download Metacast podcast app
Podcasts are better in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

Newly diagnosed HIV

HIV testing is now being routinely offered in increasingly diverse health settings, including primary care. In this podcast we talk to HIV consultant Mike Rayment, from Chelsea and Westminster NHS Foundation Trust, and Paul, a patient diagnosed with HIV infection 4 years ago. They discuss how to go about offering testing, and what matters to patients when they receive the diagnosis. Read the clinical review discussed: http://www.bmj.com/content/349/bmj.g4275

Jul 11, 201430 min

Why we need an independent WHO

Devi Sridhar, population health researcher and lecturer, joins us to discuss why an independent organisation to co-ordinate international health concerns is absolutely necessary. Read more in her analysis article, Global rules for global health: Why we need an independent, impartial WHO

Jun 20, 201415 min

FiFA, the World Cup, and the disappearing alcohol ban

Whichever country hoists aloft the World Cup trophy on 13 July, the real winner will be the alcohol industry. In this podcast Jonathan Gornall explains why FIFA promotes the interests of the alcohol industry, and the extraordinary demands countries comply with in order to host the World Cup. World Cup 2014: festival of football or alcohol? http://www.bmj.com/content/348/bmj.g3772

Jun 13, 20147 min

Drugs for weight loss

Drugs to encourage weight loss have a chequered past, with many of them having been withdrawn from the market due to increased morbidity and mortality. In this podcast Raj Padwal, associate professor of medicine at the University of Alberta, takes us through the remaining therapy Orlistat, and discusses the potential for two new therapies, Phentermine-ER topiramate, and Lorcaserin, which are being licensed in some countries Read the full article: http://www.bmj.com/content/348/bmj.g3526...

Jun 06, 201423 min

Helicobacter pylori - new evidence, and when to test and treat

Two articles on bmj.com look at helicobacter pylori; a systematic review and meta-analysis examines if eradication treatment reduces rates of gastric cancer, and an uncertainties article asks who we should be testing and treating for the infection. Two of the authors of those articles, Alex Ford from the Leeds Gastroenterology Institute, and Paul Moayyedi from the Gastroenterology Division of McMaster University, join us to discuss the bacterium. Read the full articles www.bmj.com/content/348/bm...

May 27, 201422 min

Is advice to cut down smoking wrong?

New NICE guidance says that smokers should be encouraged to cut down on the number of cigarettes they smoke, as well as trying to quit. In a head to head, published on bmj.com, Paul Aveyard, professor of behavioural medicine at the University of Oxford, says that reducing smoking is a worthwhile step towards cessation, but Gerard Hastings, professor of social marketing at Stirling and Open Universities, argues that the lifelong nicotine replacement therapy being recommended in support may benefi...

May 23, 201417 min

Investigating UTIs in older adults

UTIs are often diagnosed in secondary care, but often that diagnosis isn't accurate. In this podcast Gavin Barlow from the Department of infection and tropical medicine at Hull & East Yorkshire Hospitals NHS Trust joins us to discuss when and how to test for the infection​. Read the full clinical review Investigation of suspected urinary tract infection in older people http://www.bmj.com/content/348/bmj.g3861

May 22, 201411 min

Alcohol - The UK’s billion unit pledge is worthless

The BMJ has been investigating the “cosy relationship” between the alcohol industry and the British government. In a series of articles Under the influence, journalist Jonathan Gornall has been looking into UK government’s consultation into introducing a minimum unit price for alcohol in England and Wales, and also at the wider responsibility deal between government and industry which is meant to champion public health. In his latest article, he looks at the billion unit pledge, and how it's act...

May 21, 201420 min

Operating to remove recurrent colorectal cancer: have we got it right?

A new analysis article on bmj.com discusses the story of a surgical colon cancer trial, that was started 30 years ago and then abandoned, and the data lost. In this podcast Helen Macdonald talks to Tom Treasure from Imperial College London, who has unearthed the data and now published the research. Also joining the discussion is Peter Doshi, one of the instigators of the RIAT initiative set up to encourage this kind of work to correct the scientific record. Read the full article: http://www.bmj....

May 15, 201419 min

Patient confidentiality in the digital age

Digital technology introduces new concerns for confidentiality and information security. In this podcast Bradley Crotty and Arash Mostaghimi, both from Harvard Medical School, outline the regulations governing confidentiality and medical privacy and provide practical advice on how to safeguard patient information Read their article for more details: http://www.bmj.com/content/348/bmj.g2943

May 09, 201418 min

The problems with testosterone testing in female athletes

The International Olympic Committee (IOC) and other international sports federations have recently introduced policies which require a medical investigation of women athletes known or suspected to have hyperandrogenism. Women who are found to have naturally high testosterone levels and tissue sensitivity are banned from competition unless they have surgical or pharmaceutical interventions to lower their testosterone levels. But a recent analysis published on bmj.com says that these tests and pro...

Apr 30, 201418 min

Should doctors be prescribing cannabinoids?

Michael Farrell, professor and director of the National Drug and Alcohol Research Centre at the University of New South Wales in Sydney, talks to Mabel Chew, The BMJ's practice editor, about prescription of cannabinoids. They discuss the latest evidence on nausea and appetite, when cannabinoids may be effective for chronic pain, and which common problems to watch out for. Read the full article: http://www.bmj.com/content/348/bmj.g2737

Apr 25, 201419 min

Using HbA1c to diagnose type 2 diabetes

Glycated Haemoglobin (HbA1c) is used to measure glucose control in patients with diabetes, but can now be used as an alternative test to glucose concentration for diagnosing type 2 diabetes or identifying people at high risk of developing the disease. in this podcast Eric Kilpatrick, from the Department of Clinical Biochemistry at Hull York Medical School, and Stephen Atkin, from Weill Cornell Medical College Qatar, describe when testing HbA1c may be appropriate for diagnosis, and what comorbidi...

Apr 24, 201415 min

How to manage the first seizure in an adult

First seizure covers a wide range of manifestations, but picking up the minor events can prevent a patient from experiencing a major event, so early diagnosis is key. Heather Angus-Leppan, consultant neurologist and epilepsy lead at the Royal Free Hospital in London, talks to Navjoyt Ladher about how to manage the first seizure in an adult. Read the full clinical review at: http://www.bmj.com/content/348/bmj.g2470

Apr 14, 201430 min

Tamiflu US Press Conference

Tamiflu (oseltamivir) is a neuraminidase inhibitor, developed by Roche, for the treatment of seasonal and pandemic influenza. Yet for the first time a comprehensive review of the data, by independent researchers, has shown that the claims for Tamiflu’s effectiveness have been overestimated, and that harms have been underreported. Here is the audio of a recent press conference where researchers and the BMJ's editors describe the findings of that research, and the systematic regulatory failures th...

Apr 09, 201433 min

Triptans for the acute treatment of migraine

Mabel Chew talks to Tamara Pringsheim, from the University of Calgary, about the use of triptans for acute treatment of migraine. When, how, and what contraindications a physician should be aware of. Read the full article: http://www.bmj.com/content/348/bmj.g2285

Apr 07, 201418 min

Friends and family test: Don’t just collect data, use it

The NHS has been collecting data on patients’ experience of care for over 10 years but few providers are systematically using the information to improve services. Angela Coulter joins us to discuss the new Friends and Family test, and why it will fail to change services until it asks the right questions. read the full paper: http://www.bmj.com/content/348/bmj.g2225

Mar 27, 201414 min

Who, when and how: Screening for MRSA

Meticillin resistant Staphylococcus aureus (MRSA) remains one of the foremost hospital acquired pathogens. Patients colonised or infected with MRSA provide a reservoir within hospitals, although infection prevention and control measures minimise the risk of transmission. Although there is broad agreement on the control measures required for patients colonised or infected with MRSA, there is considerable controversy over who, when and how to screen for the bacteria. John Coia, a consultant microb...

Mar 21, 201413 min

ParkinsonNet: a new approach to management of chronic disease

Read the full analysis of ParkinsonNet: http://www.bmj.com/content/348/bmj.g1838 Patients with Parkinson’s disease need long term support to manage their condition. In this podcast Bastiaan Bloem, medical director at the Parkinsons Institute in Nijmegen, and Marko van der Vegt, a Parkinsons patient, describe the benefits of ParkinsonNet; a model of integrated care provided by a network of specialists and suggest it has promise for other long term conditions

Mar 20, 201415 min

Recognising a subdural haematoma in the elderly

Subdural haematoma is more common in elderly patients, yet the condition is easy to miss in this group. John Young, a consultant geriatrician at Bradford Teaching Hospitals NHS Foundation Trust, describes what clinical signs to look out for, and what tests can confirm a diagnosis of subdural haematoma.

Mar 11, 201419 min

The Health and Social Care bill: An end of year report

Each year at the Nuffield Trust Health Policy Summit, The BMJ hosts a breakfast roundtable. It has been one year since the Health and Social Care Bill for England was enacted, and the reconfiguration of the NHS continues, so this year we asked our panel to give the bill an end of year report. Taking part were: John Richards – Southampton Clinical Commissioning Group Nigel Edwards - CEO Nuffield Trust Jennifer Dixon - CEO Health Foundation Terence Stephenson - president Academy of Medical Royal C...

Mar 07, 201445 min

HPV vaccination and cervical cancer screening in Australia

Read the open access research: http://www.bmj.com/cgi/doi/10.1136/bmj.g1458 Australia was one of the first countries to introduce HPV vaccination, and due to it's cervical cancer screening programme, is one of the first to be able to measure the effectiveness of the vaccine. In this podcast, 3 of the authors of a new paper on bmj.com discuss their findings and talk about implications for cervical cancer screening in Australia.

Mar 06, 201422 min

Recognising and treating fibromyalgia

Most doctors are familiar with patients who describe chronic pain all over the body, which is associated with a range of other symptoms including poor sleep, fatigue, and depression. This complex of symptoms is sometimes referred to as fibromyalgia. Management of patients with this condition is often complex and challenging. The diagnosis of fibromyalgia has long been controversial, with some experts questioning whether it exists as a separate entity In this podcast Anisur Rahman, professor of r...

Feb 24, 201419 min

Steps to limit smoking in China could save 13,000,000 lives in 35 years

Complete implementation of the World Health Organization Framework Convention on Tobacco Control (WHO FCTC) recommends policies in China that would prevent almost 13m smoking related deaths by 2050, suggests a paper published on bmj.com. China is home to about one third of the world’s smokers and reducing smoking in China could have an enormous public health impact, even on a global scale. To discuss their research, we are joined by three of the paper's authors, David Levy from Georgetown Univer...

Feb 17, 201420 min

Twenty-five Year Follow-up of the Canadian National Breast Screening Study

Controversy rages over the relative benefits or harms of screening for breast cancer, with evidence suggesting that in younger women at least it does more harm than good. Now a new paper on bmj.com reports the results of 25 years of follow up of women who have taken part in a breast cancer screening trial in Canada, and suggests that annual screening does not cut breast cancer deaths. Anthony Miller, Professor Emeritus at the Dalla Lana School of Public Health, University of Toronto, lead author...

Feb 07, 201417 min

Veggie drugs

Read the full article online: http://www.bmj.com/content/348/bmj.g401 When you prescribe a drug, do you ever stop to wonder if it's suitable for vegetarians? Kinesh Patel and Kate Tatham from Imperial College London have found that 74 of the 100 drugs most commonly prescribed by GPs in the UK contain ingredients which may have been derived from animals.

Feb 05, 201412 min

BMJ podcast: Treating erectile dysfunction

Read the full article: http://www.bmj.com/content/348/bmj.g129 Erectile dysfunction is a common problem, and novel treatments mean that patient’s options have widened. In this podcast Asif Muneer, consultant urological surgeon and andrologist at University College Hospital in London, explains the aetiology, treatment, and prognosis for the condition.

Jan 27, 201417 min

BMJ podcast - high risk devices for rare conditions

Two articles on bmj.com look at high risk devices for rare conditions, and how the US Food and Drug Administration regulates them. Joining us to discuss the problems are Rita Redberg, professor of medicine at the University of California San Francisco, and Aaron Kesselheim, assistant professor of medicine at the Harvard School of Public health. Read the articles Presumed safe no more: lessons from the Wingspan saga on regulation of devices http://www.bmj.com/content/348/bmj.g93 Assessment of US ...

Jan 24, 201414 min

Why don’t WHO guidelines on fluid resuscitation in children include the FEAST trial results?

Read the article: http://www.bmj.com/content/348/bmj.f7003 The 2013 World Health Organization guidelines continue to recommend rapid fluid resuscitation for children with shock, despite evidence from the FEAST trial that this can increase mortality. Katheryn Maitland, professor of tropical paediatric infectious disease at Imperial College London, who led the FEAST trial, joins us to discuss it.

Jan 17, 201415 min

Should journals stop publishing research funded by the drug industry?

Read the head to head: http://www.bmj.com/content/348/bmj.g171 The BMJ no longer publishes research funded by tobacco companies. Richard Smith says that research funded by drug companies is also flawed and published to encourage sales, but Trish Groves says that the industries are fundamentally different and that moves are afoot to increase integrity Join the authors live on Twitter to debate the issue on 21 January, 1200-1230 GMT at #pharmaban.

Jan 15, 201416 min
For the best experience, listen in Metacast app for iOS or Android